Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Winter

Showing results (1251-1260 of 1,268) with videos related to

Pageof 127
Sort By:
Seminars in Hematology|December 6, 2001
Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombastheniaM C Poon, R d'Oiron, I Hann, et al.
Spinal Cord|March 30, 2011
United States (US) multi-center study to assess the validity and reliability of the Spinal Cord Independence Measure (SCIM III)K D Anderson, M E Acuff, B G Arp, et al.
Blood Advances|April 7, 2023
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutionsAjay Major, Jovian Yu, Navika Shukla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2019
Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical PracticeLindsey E Roeker, Christopher P Fox, Toby A Eyre, et al.
Thorax|June 10, 2022
Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trialInge A H van den Berk, Maadrika M N P Kanglie, Tjitske S R van Engelen, et al.
Annals of the Rheumatic Diseases|November 28, 2024
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adultsElizabeth M Winter, Olaf M Dekkers, Caroline M Andreasen, et al.
Blood Advances|May 19, 2019
A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLLAnthony R Mato, Lindsey E Roeker, Toby A Eyre, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 18, 2024
Combined strategy of upfront CTCA and optimal treatment for stable chest pain: rationale and design of the CLEAR-CAD trialVictor A Verpalen, Casper F Coerkamp, Mark J Hinderks, et al.
Science (New York, N.Y.)|March 9, 2023
Protein-metabolite interactomics of carbohydrate metabolism reveal regulation of lactate dehydrogenaseKevin G Hicks, Ahmad A Cluntun, Heidi L Schubert, et al.
Haematologica|June 9, 2018
Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United StatesAnthony R Mato, Meghan Thompson, John N Allan, et al.
Pageof 127

Showing results (1251-1260 of 1,268) with videos related to

Sort By:
Pageof 127
Seminars in Hematology|December 6, 2001
Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombastheniaM C Poon, R d'Oiron, I Hann, et al.
Spinal Cord|March 30, 2011
United States (US) multi-center study to assess the validity and reliability of the Spinal Cord Independence Measure (SCIM III)K D Anderson, M E Acuff, B G Arp, et al.
Blood Advances|April 7, 2023
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutionsAjay Major, Jovian Yu, Navika Shukla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2019
Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical PracticeLindsey E Roeker, Christopher P Fox, Toby A Eyre, et al.
Thorax|June 10, 2022
Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trialInge A H van den Berk, Maadrika M N P Kanglie, Tjitske S R van Engelen, et al.
Annals of the Rheumatic Diseases|November 28, 2024
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adultsElizabeth M Winter, Olaf M Dekkers, Caroline M Andreasen, et al.
Blood Advances|May 19, 2019
A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLLAnthony R Mato, Lindsey E Roeker, Toby A Eyre, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 18, 2024
Combined strategy of upfront CTCA and optimal treatment for stable chest pain: rationale and design of the CLEAR-CAD trialVictor A Verpalen, Casper F Coerkamp, Mark J Hinderks, et al.
Science (New York, N.Y.)|March 9, 2023
Protein-metabolite interactomics of carbohydrate metabolism reveal regulation of lactate dehydrogenaseKevin G Hicks, Ahmad A Cluntun, Heidi L Schubert, et al.
Haematologica|June 9, 2018
Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United StatesAnthony R Mato, Meghan Thompson, John N Allan, et al.
Pageof 127